NPS will be attending the virtual Advanced Therapies Congress & Expo 2020. Come and discuss mycoplasma detection in ATMPs. We look forward to meeting you there....
Nissui Pharma Solutions (NPS) has successfully completed an EP validation study in partnership with Confarma, a Solvias group company, specialized in biological analysis. MycoFinder, a mycoplasma gene detection kit, fulfils all requirements for EP 2.6.7. This...
Nissui Pharmaceutical Solutions (NPS) has been created by Nissui Pharmaceutical (Japan) as their European product development, sales and marketing subsidiary. Headquartered in Paris, NPS will develop and market products across Europe as part of the international...
NPS provides innovative solutions for QC/QA and product release of ATMPs and biopharmaceuticals.
Nissui Pharma Solutions
10, rue Mesnil
Sales : email@example.com
Technical support : firstname.lastname@example.org